These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33171148)

  • 21. Cannabinoid type-1 receptor blockade restores neurological phenotypes in two models for Down syndrome.
    Navarro-Romero A; Vázquez-Oliver A; Gomis-González M; Garzón-Montesinos C; Falcón-Moya R; Pastor A; Martín-García E; Pizarro N; Busquets-Garcia A; Revest JM; Piazza PV; Bosch F; Dierssen M; de la Torre R; Rodríguez-Moreno A; Maldonado R; Ozaita A
    Neurobiol Dis; 2019 May; 125():92-106. PubMed ID: 30685352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Putative Epigenetic Involvement of the Endocannabinoid System in Anxiety- and Depression-Related Behaviors Caused by Nicotine as a Stressor.
    Hayase T
    PLoS One; 2016; 11(7):e0158950. PubMed ID: 27404492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dietary intake of polyunsaturated fatty acids alleviates cognition deficits and depression-like behaviour via cannabinoid system in sleep deprivation rats.
    Wang T; Niu K; Fan A; Bi N; Tao H; Chen XT; Wang HL
    Behav Brain Res; 2020 Apr; 384():112545. PubMed ID: 32035867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Communication and social interaction in the cannabinoid-type 1 receptor null mouse: Implications for autism spectrum disorder.
    Fyke W; Premoli M; Echeverry Alzate V; López-Moreno JA; Lemaire-Mayo V; Crusio WE; Marsicano G; Wöhr M; Pietropaolo S
    Autism Res; 2021 Sep; 14(9):1854-1872. PubMed ID: 34173729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological comparison of traditional and non-traditional cannabinoid receptor 1 blockers in rodent models in vivo.
    Varga B; Kassai F; Szabó G; Kovács P; Fischer J; Gyertyán I
    Pharmacol Biochem Behav; 2017 Aug; 159():24-35. PubMed ID: 28666894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CB
    Drori A; Gammal A; Azar S; Hinden L; Hadar R; Wesley D; Nemirovski A; Szanda G; Salton M; Tirosh B; Tam J
    Elife; 2020 Nov; 9():. PubMed ID: 33210603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term effects of juvenile nicotine exposure on abstinence-related social anxiety-like behavior and amygdalar cannabinoid receptor 1 (CB1R) mRNA expression in the novelty-seeking phenotype.
    Aydin C; Oztan O; Isgor C
    Behav Brain Res; 2012 Mar; 228(1):236-9. PubMed ID: 22119710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CB1 Receptor Silencing Attenuates Ketamine-Induced Hyperlocomotion Without Compromising Its Antidepressant-Like Effects.
    Gobira PH; LaMar J; Marques J; Sartim A; Silveira K; Santos L; Wegener G; Guimaraes FS; Mackie K; Lu HC; Joca S
    Cannabis Cannabinoid Res; 2023 Oct; 8(5):768-778. PubMed ID: 36067014
    [No Abstract]   [Full Text] [Related]  

  • 29. CB1 receptors modulate affective behaviour induced by neuropathic pain.
    Rácz I; Nent E; Erxlebe E; Zimmer A
    Brain Res Bull; 2015 May; 114():42-8. PubMed ID: 25863168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endocannabinoid signaling in hypothalamic-pituitary-adrenocortical axis recovery following stress: effects of indirect agonists and comparison of male and female mice.
    Roberts CJ; Stuhr KL; Hutz MJ; Raff H; Hillard CJ
    Pharmacol Biochem Behav; 2014 Feb; 117():17-24. PubMed ID: 24316201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice.
    Shearman LP; Rosko KM; Fleischer R; Wang J; Xu S; Tong XS; Rocha BA
    Behav Pharmacol; 2003 Dec; 14(8):573-82. PubMed ID: 14665974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel allosteric modulator of the cannabinoid CB
    Mielnik CA; Sugamori KS; Finlay DB; Thorpe HHA; Schapira M; Sivananthan N; Li CK; Lam VM; Harrington S; Abdelrahman MH; Trembleau LA; McIntyre Burnham W; Khokhar JY; Salahpour A; Ramsey AJ; Glass M; Greig IR; Ross RA
    Neuropsychopharmacology; 2021 Jan; 46(2):413-422. PubMed ID: 33036015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endocannabinoid receptor deficiency affects maternal care and alters the dam's hippocampal oxytocin receptor and brain-derived neurotrophic factor expression.
    Schechter M; Weller A; Pittel Z; Gross M; Zimmer A; Pinhasov A
    J Neuroendocrinol; 2013 Oct; 25(10):898-909. PubMed ID: 23895426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice.
    Jin K; Xie L; Kim SH; Parmentier-Batteur S; Sun Y; Mao XO; Childs J; Greenberg DA
    Mol Pharmacol; 2004 Aug; 66(2):204-8. PubMed ID: 15266010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endogenous and synthetic cannabinoids induce the downregulation of cannabinoid CB1 receptor in retina.
    Papadogkonaki S; Theodorakis Κ; Thermos K
    Exp Eye Res; 2019 Aug; 185():107694. PubMed ID: 31199905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regional changes in the type 1 cannabinoid receptor are associated with cognitive dysfunction in Parkinson's disease.
    Ceccarini J; Casteels C; Ahmad R; Crabbé M; Van de Vliet L; Vanhaute H; Vandenbulcke M; Vandenberghe W; Van Laere K
    Eur J Nucl Med Mol Imaging; 2019 Oct; 46(11):2348-2357. PubMed ID: 31342135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exposure to cannabinoid agonist WIN 55,212-2 during early adolescence increases alcohol preference and anxiety in CD1 mice.
    Frontera JL; Gonzalez Pini VM; Messore FL; Brusco A
    Neuropharmacology; 2018 Jul; 137():268-274. PubMed ID: 29778010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concerted action of CB1 cannabinoid receptor and deleted in colorectal cancer in axon guidance.
    Argaw A; Duff G; Zabouri N; Cécyre B; Chainé N; Cherif H; Tea N; Lutz B; Ptito M; Bouchard JF
    J Neurosci; 2011 Jan; 31(4):1489-99. PubMed ID: 21273433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabinoid CB1 receptor in dorsal telencephalic glutamatergic neurons: distinctive sufficiency for hippocampus-dependent and amygdala-dependent synaptic and behavioral functions.
    Ruehle S; Remmers F; Romo-Parra H; Massa F; Wickert M; Wörtge S; Häring M; Kaiser N; Marsicano G; Pape HC; Lutz B
    J Neurosci; 2013 Jun; 33(25):10264-77. PubMed ID: 23785142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodents.
    Fong TM; Guan XM; Marsh DJ; Shen CP; Stribling DS; Rosko KM; Lao J; Yu H; Feng Y; Xiao JC; Van der Ploeg LH; Goulet MT; Hagmann WK; Lin LS; Lanza TJ; Jewell JP; Liu P; Shah SK; Qi H; Tong X; Wang J; Xu SS; Francis B; Strack AM; MacIntyre DE; Shearman LP
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1013-22. PubMed ID: 17327489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.